Contracts & Pricing August 11, 2020 New Drug Pricing Executive Orders, Changes to 340B 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Patient Access July 27, 2020 Real-Time Data Insights and Actionability All in Single Access-Specific Platform 4 Minute Read Refined patient data aggregation and enhanced inventory analytics. Read more about what's new in the latest ICyte Platform Summer Release.
Contracts & Pricing July 22, 2020 New News From California: Pricing Transparency, State Supplemental Program 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing June 19, 2020 The Latest Updates from the Centers for Medicare & Medicaid Services,... 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Patient Access June 10, 2020 The Four Challenge Cases in Patient Data Mastering 8 Minute Read IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...
Patient Access August 15, 2019 Utilizing AI and Machine Learning to Predict Challenging Patient Cases 3 Minute Read IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...
Patient Access July 12, 2019 Cancellation Reasons Highlight the Opportunity to Proactively Support Stalled Patient Cases 3 Minute Read The quality of status and sub-status data reported by SPs is an ongoing challenge that limits the actionability of data specialty brands have contracted to receive. Clearly, poor data...
Patient Access February 7, 2019 Specialty Pharmacy Patient Status Data Quality Challenges and Solutions 4 Minute Read Without visibility into each individual patient journey, your specialty brand cannot consistently intervene to help patients overcome barriers to therapy initiation and adherence. Today, the poor quality of specialty...
Contracts & Pricing December 12, 2018 Looking to 2019 from the Life Sciences Trade and Channel Strategic... 2 Minute Read In this post IntegriChain Senior Vice President of Sales, Gary Palgon, shares the trending topic's from the 2018 CBI Life Sciences Trade & Channel conference held in Philadelphia, Pa...
